Segment Wealth Management
TEVA icon

Segment Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Segment Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,176
Closed -$876K – 191
2016
Q4 		$876K Buy
+24,176
New +$965K 0.32% 84
2016
Q1 		– Sell
-44,297
Closed -$2.91M – 164
2015
Q4 		$2.91M Sell
44,297
-1,515
-3% -$93.6K 1.1% 31
2015
Q3 		$2.59M Buy
45,812
+3,253
+8% +$211K 0.99% 39
2015
Q2 		$2.52M Sell
42,559
-329
-0.8% -$20.3K 0.87% 42
2015
Q1 		$2.67M Buy
42,888
+5,705
+15% +$332K 0.89% 37
2014
Q4 		$2.14M Buy
37,183
+2,082
+6% +$116K 0.82% 44
2014
Q3 		$1.89M Buy
35,101
+2,372
+7% +$126K 0.72% 51
2014
Q2 		$1.72M Buy
32,729
+2,161
+7% +$110K 0.66% 51
2014
Q1 		$1.62M Buy
30,568
+5,352
+21% +$247K 0.75% 52
2013
Q4 		$1.01M Buy
25,216
+3,474
+16% +$137K 0.5% 64
2013
Q3 		$821K Buy
21,742
+1,263
+6% +$49.3K 0.45% 66
2013
Q2 		$803K Buy
+20,479
New +$798K 0.48% 62

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Highfields Capital Management
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Segment Wealth Management's TEVA Position: Q1 2017 in Review

Segment Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2017, closing a stake of 24,176 shares — an estimated $876K sold.

Segment Wealth Management first reported a position in TEVA in Q2 2013 and held it in 12 quarters. The position peaked at $2.91M in Q4 2015. 688 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

  • Segment Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2017 after selling out during the quarter.
  • Segment Wealth Management sold 24,176 Teva Pharmaceutical Industries Limited shares in Q1 2017, an estimated $876K.
  • Segment Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 12 quarters.
  • Segment Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $2.91M in Q4 2015.
  • 688 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2017.

Based on Segment Wealth Management's 13F filing for Q1 2017, filed 8 May 2017.